EVA MARÍA
CIRUELOS GIL
Profesora asociada de Ciencias de la Salud
German Cancer Research Center
Heidelberg, AlemaniaPublicaciones en colaboración con investigadores/as de German Cancer Research Center (2)
2021
2019
-
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
Annals of Oncology, Vol. 30, Núm. 5, pp. 766-773